QQQ   352.58 (+1.08%)
AAPL   179.97 (+1.21%)
MSFT   324.84 (+0.45%)
META   265.16 (+0.59%)
GOOGL   122.06 (-0.36%)
AMZN   123.82 (+2.14%)
TSLA   232.92 (+3.72%)
NVDA   386.70 (+3.19%)
NIO   7.69 (-0.90%)
BABA   86.44 (+1.36%)
AMD   120.91 (+2.61%)
T   16.02 (-0.50%)
F   13.61 (+0.15%)
MU   65.04 (-3.01%)
CGC   0.70 (-2.81%)
GE   106.79 (+0.67%)
DIS   92.36 (-0.17%)
AMC   4.66 (-1.48%)
PFE   39.06 (+0.44%)
PYPL   64.24 (+0.31%)
NFLX   405.44 (+1.42%)
QQQ   352.58 (+1.08%)
AAPL   179.97 (+1.21%)
MSFT   324.84 (+0.45%)
META   265.16 (+0.59%)
GOOGL   122.06 (-0.36%)
AMZN   123.82 (+2.14%)
TSLA   232.92 (+3.72%)
NVDA   386.70 (+3.19%)
NIO   7.69 (-0.90%)
BABA   86.44 (+1.36%)
AMD   120.91 (+2.61%)
T   16.02 (-0.50%)
F   13.61 (+0.15%)
MU   65.04 (-3.01%)
CGC   0.70 (-2.81%)
GE   106.79 (+0.67%)
DIS   92.36 (-0.17%)
AMC   4.66 (-1.48%)
PFE   39.06 (+0.44%)
PYPL   64.24 (+0.31%)
NFLX   405.44 (+1.42%)
QQQ   352.58 (+1.08%)
AAPL   179.97 (+1.21%)
MSFT   324.84 (+0.45%)
META   265.16 (+0.59%)
GOOGL   122.06 (-0.36%)
AMZN   123.82 (+2.14%)
TSLA   232.92 (+3.72%)
NVDA   386.70 (+3.19%)
NIO   7.69 (-0.90%)
BABA   86.44 (+1.36%)
AMD   120.91 (+2.61%)
T   16.02 (-0.50%)
F   13.61 (+0.15%)
MU   65.04 (-3.01%)
CGC   0.70 (-2.81%)
GE   106.79 (+0.67%)
DIS   92.36 (-0.17%)
AMC   4.66 (-1.48%)
PFE   39.06 (+0.44%)
PYPL   64.24 (+0.31%)
NFLX   405.44 (+1.42%)
QQQ   352.58 (+1.08%)
AAPL   179.97 (+1.21%)
MSFT   324.84 (+0.45%)
META   265.16 (+0.59%)
GOOGL   122.06 (-0.36%)
AMZN   123.82 (+2.14%)
TSLA   232.92 (+3.72%)
NVDA   386.70 (+3.19%)
NIO   7.69 (-0.90%)
BABA   86.44 (+1.36%)
AMD   120.91 (+2.61%)
T   16.02 (-0.50%)
F   13.61 (+0.15%)
MU   65.04 (-3.01%)
CGC   0.70 (-2.81%)
GE   106.79 (+0.67%)
DIS   92.36 (-0.17%)
AMC   4.66 (-1.48%)
PFE   39.06 (+0.44%)
PYPL   64.24 (+0.31%)
NFLX   405.44 (+1.42%)
NASDAQ:TRHC

Tabula Rasa HealthCare (TRHC) Stock Forecast, Price & News

$6.30
+0.24 (+3.96%)
(As of 02:34 PM ET)
Compare
Today's Range
$6.04
$6.35
50-Day Range
$5.11
$6.06
52-Week Range
$2.33
$6.69
Volume
138,276 shs
Average Volume
117,250 shs
Market Capitalization
$169.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.63

Tabula Rasa HealthCare MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
5.2% Upside
$6.63 Price Target
Short Interest
Bearish
5.79% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.91) to ($0.99) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.07 out of 5 stars

Medical Sector

958th out of 981 stocks

Business Services, Not Elsewhere Classified Industry

90th out of 90 stocks


TRHC stock logo

About Tabula Rasa HealthCare (NASDAQ:TRHC) Stock

Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.

Receive TRHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter.

TRHC Stock News Headlines

New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
Q1 2023 Tabula Rasa HealthCare Inc Earnings Call
8-K: Tabula Rasa HealthCare, Inc.
Tabula Rasa HealthCare Provides Corporate Updates
Q4 2022 Tabula Rasa HealthCare Inc Earnings Call
See More Headlines

TRHC Price History

TRHC Company Calendar

Last Earnings
5/08/2023
Today
6/08/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TRHC
Fax
N/A
Employees
1,027
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.63
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+5.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-147,510,000.00
Pretax Margin
-19.88%

Debt

Sales & Book Value

Annual Sales
$320.68 million
Book Value
($2.10) per share

Miscellaneous

Free Float
18,715,000
Market Cap
$169.16 million
Optionable
Optionable
Beta
1.54

Key Executives

  • Brian W. AdamsBrian W. Adams
    President, Chief Executive Officer & Director
  • Michael GreenhalghMichael Greenhalgh
    Chief Operating Officer
  • Thomas J. Cancro
    Chief Financial & Accounting Officer
  • Joseph J. Filippoli
    Chief Information Officer
  • Jacques Turgeon
    Chief Scientific Officer













TRHC Stock - Frequently Asked Questions

Should I buy or sell Tabula Rasa HealthCare stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TRHC shares.
View TRHC analyst ratings
or view top-rated stocks.

What is Tabula Rasa HealthCare's stock price forecast for 2023?

4 brokers have issued twelve-month price targets for Tabula Rasa HealthCare's shares. Their TRHC share price forecasts range from $5.00 to $10.00. On average, they anticipate the company's share price to reach $6.63 in the next year. This suggests a possible upside of 5.2% from the stock's current price.
View analysts price targets for TRHC
or view top-rated stocks among Wall Street analysts.

How have TRHC shares performed in 2023?

Tabula Rasa HealthCare's stock was trading at $4.95 at the beginning of 2023. Since then, TRHC stock has increased by 27.3% and is now trading at $6.30.
View the best growth stocks for 2023 here
.

Are investors shorting Tabula Rasa HealthCare?

Tabula Rasa HealthCare saw a drop in short interest in May. As of May 15th, there was short interest totaling 1,380,000 shares, a drop of 13.8% from the April 30th total of 1,600,000 shares. Based on an average trading volume of 116,800 shares, the days-to-cover ratio is presently 11.8 days. Currently, 5.8% of the shares of the stock are sold short.
View Tabula Rasa HealthCare's Short Interest
.

When is Tabula Rasa HealthCare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our TRHC earnings forecast
.

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its quarterly earnings results on Monday, May, 8th. The company reported ($0.12) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.19. The company earned $88.28 million during the quarter, compared to analysts' expectations of $83.86 million. Tabula Rasa HealthCare had a negative trailing twelve-month return on equity of 472.90% and a negative net margin of 42.17%.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare issued an update on its second quarter 2023 earnings guidance on Monday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $88.00 million-$90.00 million, compared to the consensus revenue estimate of $85.94 million.

What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?

24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX).

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include UBS Group AG (4.84%), Wasatch Advisors LP (3.27%), JPMorgan Chase & Co. (1.18%), Acadian Asset Management LLC (1.15%), Geode Capital Management LLC (0.92%) and Spears Abacus Advisors LLC (0.88%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton, Samira Beckwith and Thomas Cancro.
View institutional ownership trends
.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $6.30.

How much money does Tabula Rasa HealthCare make?

Tabula Rasa HealthCare (NASDAQ:TRHC) has a market capitalization of $169.16 million and generates $320.68 million in revenue each year. The company earns $-147,510,000.00 in net income (profit) each year or ($5.54) on an earnings per share basis.

How many employees does Tabula Rasa HealthCare have?

The company employs 1,027 workers across the globe.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The official website for the company is www.tabularasahealthcare.com. The company can be reached via phone at (866) 648-2767 or via email at tabularasa@westwicke.com.

This page (NASDAQ:TRHC) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -